黑料官网

header-logo
Research Lab Bench
Physiology
Yamaka Kosuke

Kosuke Yamaka, ME, PhD

Postdoctoral Researcher

Locations

  • Physiology, 黑料官网
  • BSB 5355A

Contact Information

Education

PhD, Shinshu University Graduate School of Medicine, Matsumoto, Japan, 2025
MD, Shinshu University School of Medicine, Matsumoto, Japan, 2015

Honors and Awards

2026: AJP-Renal Physiology Top-Scoring Postdoctoral Oral Presentation Award, APS Control of Renal Function in Health and Disease
2023: The Hikawa Forum Best Presentation Award, Fall 2023
2023: The Hikawa Forum Best Presentation Award, Spring 2023

Research Interests

I received my medical training in Japan and subsequently practiced as a nephrologist, caring for patients with hypertension, chronic kidney disease, and a broad range of renal disorders. Through this clinical experience, I became increasingly interested in how disturbances in renal metabolism and fluid and electrolyte homeostasis contribute to the development and progression of hypertension and kidney disease. My previous basic research focused on the consequences of impaired renal fatty acid metabolism, with particular emphasis on the transcription factor peroxisome proliferator-activated receptor alpha (PPARα). Using a proximal tubule-specific PPARα-deficient mouse model under metabolic stress, I demonstrated that reduced renal PPARα activity promotes lipid accumulation and lipotoxicity, thereby exacerbating kidney injury. I also showed that metabolic dysfunction originating in the kidney can influence lipotoxicity in distant organs, including the liver and heart. These findings shaped my broader interest in the kidney as both a target and a potential driver of systemic metabolic disease. In parallel, my clinical research has explored the relationship between sphingolipids and kidney disease, including the role of sulfatide, a glycosphingolipid, in renal pathology. I am currently a postdoctoral researcher in the laboratory of Dr. Allen W. Cowley Jr. at the 黑料官网, where I investigate the renal mechanisms underlying salt-sensitive hypertension. My work integrates transcriptomics, metabolomics, spatial lipidomics, and renal physiology to distinguish adaptive from maladaptive responses to high salt intake in the renal cortex. Recent analyses have identified renal metabolic pathways, including sphingolipid metabolism, as candidate molecular responses associated with salt-sensitive hypertension, and I am working to define their mechanistic and physiological significance. My long-term research interests lie at the intersection of renal metabolism, hypertension, and kidney disease. By integrating my clinical perspective as a nephrologist with mechanistic and physiological approaches, I hope to advance our understanding of how metabolic pathways contribute to renal and cardiovascular disease.

Publications

  • (Harada M, Aso S, Nimura T, Yamaka K, Aomura D, Yamada A, Sonoda K, Yamaguchi A, Kamimura Y, Ichikawa T, Kobayashi M, Hashimoto K, Kamijo Y.) J Pers Med. 2026 Mar 07;16(3) PMID: 41893021 PMCID: PMC13028148 03/27/2026

  • (Aomura D, Nimura T, Yamaka K, Yamada Y, Harada M, Nakajima T, Kimura T, Hashimoto K, Kanno H, Yanagita M, Gonzalez FJ, Tanaka N, Kamijo Y.) FASEB J. 2026 Jan 15;40(1):e71333 PMID: 41460648 PMCID: PMC12747219 12/29/2025

  • (Kobayashi H, Ota M, Matsuzaki K, Yamada H, Aomura D, Joshita N, Midorikawa H, Nimura T, Yamaka K, Kurasawa Y, Suyama K, Misawa H, Joshita S.) Hepatol Res. 2025 Dec;55(12):1568-1575 PMID: 40782354 08/10/2025

  • (Tonouchi Y, Hashimoto K, Iwabuchi R, Sakai H, Nimura T, Yamaka K, Nishikawa M, Yamaguchi A, Sonoda K, Kamijo Y.) BMC Nephrol. 2025 Nov 03;26(1):611 PMID: 41184788 PMCID: PMC12581422 11/04/2025

  • (Yamaka K, Aomura D, Harada M, Nimura T, Hashimoto K, Kamijo Y.) Tohoku J Exp Med. 2025 Aug 27;266(4):381-386 PMID: 39443137 10/24/2024

  • (Nimura T, Harada M, Aomura D, Yamaka K, Hashimoto K, Kamijo Y.) Clin Exp Nephrol. 2025 Aug;29(8):1063-1074 PMID: 40100518 PMCID: PMC12331761 03/18/2025

  • (Yamaka K, Aomura D, Harada M, Nakajima T, Nimura T, Hashimoto K, Tanaka N, Kamijo Y.) Front Immunol. 2025;16:1571147 PMID: 40589750 PMCID: PMC12206770 07/01/2025

  • (Nimura T, Aomura D, Harada M, Yamaguchi A, Yamaka K, Nakajima T, Tanaka N, Ehara T, Hashimoto K, Kamijo Y.) Int J Mol Sci. 2024 Jan 09;25(2) PMID: 38255886 PMCID: PMC10815804 01/23/2024

  • (Aomura D, Harada M, Nakajima T, Nimura T, Yamaka K, Yamada Y, Hashimoto K, Tanaka N, Kamijo Y.) Front Immunol. 2023;14:1271741 PMID: 38111574 PMCID: PMC10726124 12/19/2023

  • (Okumura T, Kimura T, Nakajima D, Kondo S, Kako S, Takahashi Y, Yamaka K, Ichinohe F, Tsukahara Y, Nagaya T, Umemura T.) Radiol Case Rep. 2023 Jan;18(1):97-99 PMID: 36324839 PMCID: PMC9619333 11/04/2022

Publications of from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.